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p < 0.001). Among children under two years of 
age, PCV13 uptake increased from 2011 to 2012 
(Table 1). Antibiotic consumption in the month 
preceding sampling was higher in the urban area. 
Pneumococcal carriage ranged between 60% and 
65% in both regions and years. 
Table 1. Characteristics of the two regions in both years.
A lower percentage of VTs was observed in the 
rural area when compared to the urban area 
(18.1% vs. 23.7%, p = 0.054). 
Furthermore, the six PCV13 additional serotypes 
(1, 3, 5, 6A, 7F and 19A) were mainly found 
among children who had not received PCV13 
(24.4% vs. 12.8% in 2011, p = 0.027, and 27.6% vs. 
6.6% in 2012, p < 0.001). 
In the urban area serotypes 21, 19F, 10A, 6C and 
15B/C were the most prevalent in 2011, whereas 
serotypes 23B, NT, 6C, 3 and 35B were the most 
prevalent in 2012.
In the rural area serotypes 11A, 23A, 22F, 24F and 
6C were the most prevalent in 2011, and serotypes 
15B/C, 31, 23B, 15A and 3 were the most prevalent 
in 2012.
Around 80% of all isolates were susceptible to 
the antibiotics tested in both years. Regarding the 
resistant isolates, these were mostly non-vaccine 
types (58.1% in 2011 and 72.2% in 2012).
4. Conclusion
PCV13 is impacting on colonization and the six 
additional vaccine-types (1, 3, 5, 6A, 7F and 19A) 
were mostly detected in non-immunized children. 
Further studies are needed in the upcoming years 
to monitor and unequivocally establish the impact 
of PCV13 in colonization.
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ABSTRACT: 
The vast majority of  infections are caused by microorganisms grown as biofilms. Recent 
evidences from several laboratories have demonstrated that both in vivo and in vitro formation of 
pneumococcal biofilms are hindered by the presence of capsular polysaccharide. We have analyzed 
the biofilm-forming capacity of clinical pneumococcal isolates of various serotypes. Strains of 
serotypes 19A and 19F, but not 19B and 19C, formed ≥80% of the biofilm of the nonencapsulated 
control strain. Strains of serogroup 6 also showed a significant biofilm-forming capacity. Serotypes 
19A and 19F and serogroup 6 have in their structures the disaccharides α-D-Glcp-(1→2)-α-L-
Rhap-(1→ and α-D-Glcp-(1→3)-α-L-Rhap-(1→. Serotypes 18A and 18C have a very similar 
disaccharide: α-D-GlcpNAc-(1→3)-β-L-Rhap-(1→ and α-D-Glcp-(1→3)-β-L-Rhap-(1→, 
respectively; however, pneumococcal strains of these serotypes showed impaired biofilm formation. 
Our results indicate that the chemical composition/structure of the capsular polysaccharide is 
crucial to define the biofilm-forming capacity of a particular S. pneumoniae isolate.
Keywords: capsular polysaccharide, biofilm formation.
1. Introduction
The pneumococcal population has changed since 
the widespread introduction of PCV7, directed 
at 7 (4, 6B, 9V, 14, 18C, 19F, and 23F) of the 94 
pneumococcal capsular serotypes known to date. 
Non-PCV7 serotype isolates have increased among 
asymptomatic carriers and, to a lesser extent, 
non-PCV7 serotype pneumococci have increased 
as causes of invasive pneumococcal disease [1]. 
Hence, an increase in the incidence of infections 
caused by multiresistant 19A pneumococci has 
been observed [2].
It is now widely recognized that the vast majority 
of infections are caused by microorganism grown 
as biofilms. A biofilm is defined as a thin layer of 
microorganisms that adhere to the surface of an 
organic or inorganic structure embedded in an 
extracellular matrix [3]. Recent evidences from 
several laboratories have demonstrated that both 
in vivo and in vitro formation of pneumococcal 
biofilms is hindered by the presence of  cap-
sular polysaccharide (CPS) [4] and that exists 
an inverse relationship between the ability of the 
nonencapsulated variants to form biofilms and the 
amount of CPS produced [5].
To gain further information on the role of CPS 
in the initial steps of biofilm formation, we have 
analyzed the capacities of clinical pneumococcal 
isolates of various serotypes to develop biofilms. 
In contrast with the previous belief, some of 
the clinical serotypes analyzed are good biofilm 
formers, which may explain its prevalence in the 
human nasopharynx.
2. Results
The analysis of biofilm-forming capacity of various 
serogroup 19 pneumococcal isolates showed that 
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of the biofilm of the control, nonencapsulated 
strain M11. In contrast, strains belonging 
to serotypes 19B and 19C showed a drastic 
reduction in the number of biofilm-associated 
sessile cells. Similar results were observed with the 
corresponding isogenic capsular transformants 
producing serogroup 19 capsules, generated to 
reduce the genetic variability among strains.
A close comparison of  the primary structures 
of  the repeating units of  the CPS of  types 
19F/A on one hand, and 19B/C on the other, 
suggested that the disaccharides α-D-Glcp-
(1→2)-α-L-Rhap-(1→ and α-D-Glcp-(1→3)-α-
L-Rhap-(1→ (present in serotypes 19F and 19A 
CPSs, respectively, but not in the 19B and 19C 
capsules) may be important for promoting biofilm 
formation in the pneumococcus.
The disaccharide α-D-Glcp-(1→3)-α-L-Rhap-(1→ 
is also present in the CPS of the four serotypes of 
the serogroup 6. Previous studies of the biofilm-
forming capacity showed that serotype 6B isolates 
formed 70% of the biofilm of strain M11 [6]. The 
analysis of others members of this group, namely 
serotypes 6A and 6C, showed that both, clinical and 
M11 transformants expressing these capsules, were 
able to form more than 50% of the biofilm of the 
nonen-capsulated control strain.
Biofilm-formation capacity was also studied 
in serotypes 18A and 18C. Serotype 18C has 
a glycerol-phosphate substituent that must be 
preserved for conserving the adequate anti-
genicity of the 18C capsular polysaccharide [7]. 
Serotypes 18A and 18C have in their structure 
the disaccharides α-D-GlcpNAc-(1→3)-β-L-
Rhap-(1→ and α-D-Glcp-(1→3)-β-L-Rhap-(1→, 
respectively, very similar to the ones mentioned 
above. However, a single isolate of either serotype 
able to form a significant biofilm was not found.
3. Conclusion
The results presented in this study indicate that, in 
addition to its genetic background, the chemical 
composition/structure of CPS is crucial to define 
the biofilm-forming capacity of a particular S. 
pneumoniae isolate.
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ABSTRACT: 
Biofilm matrices consist of a mixture of extracellular polymeric substances synthesized in large 
part by the biofilm-producing microorganisms themselves. These matrices are responsible for the 
cohesion and three-dimensional architecture of biofilms. The present study demonstrates the 
existence of a matrix composed of extracellular DNA, proteins and polysaccharides in the biofilm 
formed by Streptococcus pneumoniae. Extracellular DNA, visualized by fluorescent labeling, was 
an important component of the matrix. The existence of DNA–protein complexes associated 
with bacterial aggregates and other polymers was hypothesized based on the unexpected DNA 
binding activity of lysozyme LytC. The presence of intercellular DNA-LytC protein complexes 
in pneumococcal biofilms was demonstrated by confocal laser scanning microscopy. Evidence of 
extracel-lular polysaccharide different from the capsule was obtained by staining with Calcofluor 
dye and four types of lectin conjugated to Alexa fluorophores, and by incubation with glycoside 
hydrolases. The presence of residues of Glcp(1,4) and GlcNAc(1,4) in the pneumococcal biofilm 
was confirmed by GC-MS techniques.
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1. Introduction
Recent reports have shown the in vivo for-mation 
of S. pneumoniae biofilms on adenoid and mucosal 
epithelial tissues in children with recurrent or 
chronic ear infections (for a recent review, see 
ref. 1). Using low-temperature scanning electron 
microscopy (LTSEM) techniques, we reported a 
biofilm matrix containing an intercellular, fiber-
like material that linked the pneumococcal cells to 
one another and to the glass substrate on which 
they were grown [2]. The presence of extracellular 
proteins in this matrix was inferred from the 
biofilm-disaggregating activity of  proteolytic 
enzymes [2]. 
Several authors have reported extracellular 
DNA (eDNA) to be an important extracellular 
polymeric substance (EPS) in pneumococcal 
biofilms, based on the dramatic disappearance 
and inhibited formation of  biofilms following 
treatment with DNase [2]. 
Controversy exists over whether extracellular 
polysaccharide is a component of  the S. 
pneumoniae biofilm matrix. Using encapsulated 
S. pneumoniae cells to demonstrate the existence 
of a polysaccharide among the EPS is, however, 
problematic since some lectins also bind the 
capsular polysaccharide, as demonstrated more 
than 30 years ago [3]. 
The present work provides evidence that the 
biofilm formed by S. pneumoniae R6 contains 
a matrix made up of  eDNA, protein and 
polysaccharide components. 
